India’s Light Vehicle wholesale figures for September increased by 15% month-on-month to 437k units, reports GlobalData.

The average one-year price target for GlobalData (OTCPK:GLDAF) has been revised to $3.24 / share. This is a decrease of 18.20% from the prior estimate of $3.96 dated April 24, 2025. The price target ...

The number of early-stage rounds contracted by 3% to 5,871 from 6,082 deals during Q1-Q3 2025, compared to Q1-Q3 2024, while ...

The FDA’s verdict on Poherdy comes amid Perjeta creator Genentech’s patent infringement lawsuit against Organon and Shanghai ...

Owlet has partnered with Rhapsody to integrate data from its at-home pulse oximeter, BabySat, directly into the patient’s EHRs.

Two of America’s most embattled retail chains are working together to drum up some excitement from customers this holiday season. They sure could use it. Beginning Monday, a Frozen Peppermint Hot ...

A new whitepaper from Alleima explores how guidewire technology is evolving with the growing prevalence of chronic conditions ...

Companies that align with existing international standards will have a competitive edge when regulation becomes fully ...

At AHA 2025, data from the SCORE-HF study (NCT07141914) were presented, evaluating Novo Nordisk’s semaglutide 2.4mg and its effect on cardiovascular outcomes in patients with heart failure (HF).

In its third quarter alone, TikTok Shop sold $19 billion worth of merchandise globally, according to recent data from analytics firm EchoTik. That’s just slightly below the total for eBay - founded ...

Preclinical data with a gene therapy has shown potential to restore cardiac function in a rat model of for heart failure.

If Roche's fenebrutinib got the FDA go-ahead, it would become the first BTK inhibitor to gain approval in both RMS and PPMS.